Lupus anticoagulant: influence on the international normalized ratio
Arnout, J.; Vermylen, J.
Thrombosis and Haemostasis 81(5): 847-849
1999
ISSN/ISBN: 0340-6245 PMID: 10365765 Document Number: 506405
Document emailed within 1 workday
Related Documents
Tripodi, A.; Arbini, A.A.; Chantarangkul, V.; Bettega, D.; Mannucci, P.M. 1993: Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thrombosis and Haemostasis 70(6): 921-924Della Valle, P.; Crippa, L.; Safa, O.; Tomassini, L.; Pattarini, E.; Vigano-D'Angelo, S.; Grazia Sabbadini, M.; D'Angelo, A. 1996: Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants Annales de Medecine Interne 147(Suppl): 10-14
Carroll, W.E.; Jackson, R.D. 1999: Modified anticoagulant therapy factor and international normalized ratio in patients in an unstable coagulation state with respect to warfarin therapy Research Communications in Molecular Pathology and Pharmacology 105(3): 262-270
Chantarangkul, V.; Tripodi, A.; Clerici, M.; Negri, B.; Mannucci, P.M. 1998: Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations Thrombosis and Haemostasis 80(2): 258-262
Nozawa, T.; Hayashi, S.; Naiki, S.; Niiya, K.; Asanoi, H.; Inoue, H. 1998: Inter-institute variations in International Normalized Ratio and thrombotest Journal of Cardiology 32(2): 89-94
Lecompte, T.; Samama, M.M. 1990: Monitoring of treatment with vitamin K antagonists: a plea for "INR" (International Normalized Ratio) La Revue du Praticien 40(6): 563-565
Lehman, N.; Bryant, G.; Bender, J.; Koenigsfeld, C.; Logemann, C.; Sayler, M. 2015: Left subconjunctival hemorrhage · renal dysfunction · international normalized ratio of 4.5 · Dx? Journal of Family Practice 64(10): E3-E4
Beck, E.A. 1985: From Quick's percentage to the INR (International Normalized Ratio)--a real advance in the control of oral anticoagulation Schweizerische Medizinische Wochenschrift 115(40): 1378-1380
Berkovskiĭ, A.L.; Sergeeva, E.V.; Suvotov, A.V.; Ul'ianova, I.S.; Kachalova, N.D.; Kulina, T.V.; Klimovich, L.G.; Samsonova, N.N.; Kozlov, A.A. 2006: Modified capillary blood prothrombin-time test for the calculation of an international normalized ratio Klinicheskaia Laboratornaia Diagnostika 2006(7): 44-46
Sirithunyanont, C.; Bhuripanyo, K.; Kangkagate, C.; Winyarat, W.; Srichaya, P.; Wangtip, K. 2003: Accuracy of international normalized ratio determined by portable venous-blood coagulation monitor versus a central laboratory Journal of the Medical Association of Thailand 86 Suppl. 1: S67-S75
Horstkotte, D.; Bergemann, R.; Oelert, H.; Schulte, H.D.; Laas, J.; Zerkowski, H.R. 1998: Increased acceptance of the International Normalized Ratio (INR) as a monitoring parameter of oral anticoagulation therapy in Germany. GELIA Study Group Zeitschrift für Kardiologie 87(10): 837-843
Yamamuro, F.; Miki, A.; Kondo, G.; Maeda, T.; Satoh, H.; Hori, S.; Sawada, Y. 2011: Individual differences in prothrombin time-international normalized ratio variation following coadministration of the anticancer agents S-1 and warfarin: 3 case reports International Journal of Clinical Pharmacology and Therapeutics 49(11): 700-704
Yu, H-Yu.; Liu, C-Ho.; Chen, Y-Sharng.; Wang, S-Shen.; Chu, S-Hsun.; Lin, F-Yue. 2005: Relationship of international normalized ratio to bleeding and thromboembolism rates in Taiwanese patients receiving vitamin K antagonist after mechanical valve replacement Journal of the Formosan Medical Association 104(4): 236-243
Poller, L.; Keown, M.; Chauhan, N.; Shiach, C.; van den Besselaar, A.M.H.P.; Tripodi, A.; Jespersen, J. 2002: European Concerted Action on Anticoagulation (ECAA): International Normalized Ratio variability of CoaguChek and TAS point-of-care testing whole blood prothrombin time monitors Thrombosis and Haemostasis 88(6): 992-995
Wysocka, K.; Kiczak, J.; Pozorska, D. 1977: Immunocoagulopathy (lupus anticoagulant) with severe hemorrhagic diathesis in systemic lupus erythematosus Wiadomosci Lekarskie 30(14): 1129-1134
Engelsen, J.; Nielsen, S.M.; Thorsen, S. 2006: Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome Ugeskrift for Laeger 168(5): 486-487
Asherson, R.A.; Lanham, J.G.; Hull, R.G.; Boey, M.L.; Gharavi, A.E.; Hughes, G.R. 1984: Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant" Clinical and Experimental Rheumatology 2(1): 75-79
Destée, A.; Devos, P.; Prin, L.; Warot, M.; Warot, P. 1985: Brain stem infarction, systemic lupus erythematosus and circulating lupus anticoagulant Revue Neurologique (Paris) 141(3): 236-239
Raleigh-Rosendo, R.; Diez-Ewald, M.; Vizcaíno, G.; Fereira, H.; Arteaga-Vizcaíno, M.; Arreaza, M. 1990: Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities Investigacion Clinica 31(1): 45-55
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526